Doha: The Second Forum of Naufar, focusing on the "Precision Medicine Approach in Treating Substance Use Disorders," concluded Monday.
According to Qatar News Agency, HE Minister of Public Health Mansoor bin Ebrahim Al Mahmoud inaugurated the two-day forum at Naufar. The opening ceremony was attended by a distinguished assembly of senior officials, leading experts in the healthcare sector, and representatives from academic bodies and international organizations.
This two-day event builds upon the significant success of its inaugural iteration in the preceding year, which established new benchmarks for scholarly discourse and collaborative efforts within the domains of addiction treatment and precision medicine.
In his keynote address, Prof. Mohammed Ghanem Al Ali Al Maadheed, Director General of Naufar, emphasized the critical importance of building upon prior accomplishments. He stated, "The continued iteration of this scientific symposium, following the considerable success of its inaugural event, reflects Naufar's unwavering commitment to its leading role in the advancement of specialised healthcare for the treatment of substance misuse disorders. We firmly believe that precision medicine represents a pivotal advancement in therapeutic approaches, and we are dedicated through this symposium to fostering robust collaboration and the exchange of in-depth expertise to identify innovative and efficacious solutions that effectively address the evolving needs of both patients and the broader community."
Furthermore, he asserted the substantial significance of precision medicine in the treatment of addiction, encouraging all attendees to leverage the insights and outcomes of the conference.
Across two days, the symposium's sessions covered a comprehensive range of critical topics, including the impact of genomics and pharmacogenetics in tailoring addiction treatment to individual patient profiles, advances in medication-assisted treatment (MAT) and therapies targeting the gut-brain axis, addressing challenges such as polysubstance abuse, psychiatric comorbidities, and gaming disorder, and focused sessions on mental health and precision physiotherapy for athletes with SUDs.
The symposium continued today with interactive workshops designed to foster collaboration and develop innovative strategies for tackling addiction.
Deputy Director General of Naufar, Dr. Khalifa Al Kuwari, highlighted the organization's commitment to holistic, patient-centric treatment that prioritizes individualized care and comprehensive well-being.
Naufar, a CARF-accredited center for the third consecutive cycle, remains dedicated to delivering comprehensive, patient-centered care aligned with the latest scientific evidence and international standards. The institution is committed to empowering patients and families to rebuild their lives through integrated programs spanning diagnosis, rehabilitation, and community support.